ID

31771

Beschrijving

Flupirtine as Oral Treatment in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00623415

Link

https://clinicaltrials.gov/show/NCT00623415

Trefwoorden

Versies (1)
  1. 27-09-18 27-09-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

27 september 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

Engels

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsing-remitting ms according to the revised mcdonald-criteria (2005)
Beschrijving

Multiple Sclerosis, Relapsing-Remitting

Datatype

boolean

Alias
UMLS CUI [1]
C0751967
edss ≤ 4.0
Beschrijving

EDSS

Datatype

boolean

Alias
UMLS CUI [1]
C0451246
stable treatment with interferon-β1b for at least 6 months
Beschrijving

Interferon beta-1b Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0244713
UMLS CUI [1,2]
C0205360
sufficient birth control (pearl-index <1)
Beschrijving

Contraceptive methods | Other Coding

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C3846158
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other ms-course than rrms
Beschrijving

Multiple Sclerosis Except Relapsing-Remitting Multiple Sclerosis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0751967
clinically relevant gastrointestinal disease
Beschrijving

Gastrointestinal Diseases

Datatype

boolean

Alias
UMLS CUI [1]
C0017178
clinically relevant pulmonary, cardiological, infectious or cns-disease
Beschrijving

Lung disease | Heart Disease | Communicable Disease | CNS disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0024115
UMLS CUI [2]
C0018799
UMLS CUI [3]
C0009450
UMLS CUI [4]
C0007682
clinically relevant disease of liver or bile system, pathological value for transaminases, gamma-gt or bilirubin.
Beschrijving

Liver disease | Bile Duct Disease | Transaminases abnormal | Gamma-GT abnormal | Bilirubin abnormal

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0005395
UMLS CUI [3]
C1328397
UMLS CUI [4]
C0541979
UMLS CUI [5]
C1142335
hepatitis (except uncomplicated hepatitis a with complete remission
Beschrijving

Hepatitis | Exception Hepatitis A Uncomplicated In complete remission

Datatype

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0019159
UMLS CUI [2,3]
C0443334
UMLS CUI [2,4]
C0677874
clinically relevant dysfunction of kidneys (creatinine >180 µmol/l) or bone marrow (hb < 8.5 g/dl, wbc < 2.5/nl thrombocytes < 125/nl)
Beschrijving

Renal dysfunction | Creatinine measurement, serum | Bone Marrow Dysfunction | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement

Datatype

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C3887504
UMLS CUI [4]
C0518015
UMLS CUI [5]
C0023508
UMLS CUI [6]
C0032181
myasthenia gravis
Beschrijving

Myasthenia Gravis

Datatype

boolean

Alias
UMLS CUI [1]
C0026896
oral anticoagulation (phenprocoumon)
Beschrijving

Oral anticoagulants | Phenprocoumon

Datatype

boolean

Alias
UMLS CUI [1]
C0354604
UMLS CUI [2]
C0031444
treatment with carbamazepine or paracetamol
Beschrijving

Carbamazepine | Paracetamol

Datatype

boolean

Alias
UMLS CUI [1]
C0006949
UMLS CUI [2]
C0000970
drug or alcohol abuse
Beschrijving

Substance Use Disorders

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
pregnancy or lactation period
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
treatment at any time before or during study with complete lymphoradiation, monoclonal antibodies (e.g. anti-cd4, campath 1h, natalizumab), mitoxantrone, cyclophosphamide, cyclosporin, azathioprine
Beschrijving

Lymphatic Radiation Therapy Complete | Monoclonal Antibody Therapy | Anti-CD4 Monoclonal Antibody | Campath 1H | natalizumab | Mitoxantrone | Cyclophosphamide | Cyclosporine | Azathioprine

Datatype

boolean

Alias
UMLS CUI [1,1]
C0086572
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C0279694
UMLS CUI [3]
C3831519
UMLS CUI [4]
C1178562
UMLS CUI [5]
C1172734
UMLS CUI [6]
C0026259
UMLS CUI [7]
C0010583
UMLS CUI [8]
C0010592
UMLS CUI [9]
C0004482
treatment within 6 months before randomization with any other immunomodulatory substance than interferon-β1b or intravenous methylprednisolone
Beschrijving

Biological Response Modifiers | Exception Interferon beta-1b | Exception Methylprednisolone Intravenous

Datatype

boolean

Alias
UMLS CUI [1]
C0005525
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0244713
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0025815
UMLS CUI [3,3]
C1522726
Terug naar het begin van de pagina

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT00623415

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting ms according to the revised mcdonald-criteria (2005)
boolean
C0751967 (UMLS CUI [1])
EDSS
Item
edss ≤ 4.0
boolean
C0451246 (UMLS CUI [1])
Interferon beta-1b Stable
Item
stable treatment with interferon-β1b for at least 6 months
boolean
C0244713 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Contraceptive methods | Other Coding
Item
sufficient birth control (pearl-index <1)
boolean
C0700589 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Multiple Sclerosis Except Relapsing-Remitting Multiple Sclerosis
Item
any other ms-course than rrms
boolean
C0026769 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0751967 (UMLS CUI [1,3])
Gastrointestinal Diseases
Item
clinically relevant gastrointestinal disease
boolean
C0017178 (UMLS CUI [1])
Lung disease | Heart Disease | Communicable Disease | CNS disorder
Item
clinically relevant pulmonary, cardiological, infectious or cns-disease
boolean
C0024115 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
C0007682 (UMLS CUI [4])
Liver disease | Bile Duct Disease | Transaminases abnormal | Gamma-GT abnormal | Bilirubin abnormal
Item
clinically relevant disease of liver or bile system, pathological value for transaminases, gamma-gt or bilirubin.
boolean
C0023895 (UMLS CUI [1])
C0005395 (UMLS CUI [2])
C1328397 (UMLS CUI [3])
C0541979 (UMLS CUI [4])
C1142335 (UMLS CUI [5])
Hepatitis | Exception Hepatitis A Uncomplicated In complete remission
Item
hepatitis (except uncomplicated hepatitis a with complete remission
boolean
C0019158 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0019159 (UMLS CUI [2,2])
C0443334 (UMLS CUI [2,3])
C0677874 (UMLS CUI [2,4])
Renal dysfunction | Creatinine measurement, serum | Bone Marrow Dysfunction | Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement
Item
clinically relevant dysfunction of kidneys (creatinine >180 µmol/l) or bone marrow (hb < 8.5 g/dl, wbc < 2.5/nl thrombocytes < 125/nl)
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C3887504 (UMLS CUI [3,2])
C0518015 (UMLS CUI [4])
C0023508 (UMLS CUI [5])
C0032181 (UMLS CUI [6])
Myasthenia Gravis
Item
myasthenia gravis
boolean
C0026896 (UMLS CUI [1])
Oral anticoagulants | Phenprocoumon
Item
oral anticoagulation (phenprocoumon)
boolean
C0354604 (UMLS CUI [1])
C0031444 (UMLS CUI [2])
Carbamazepine | Paracetamol
Item
treatment with carbamazepine or paracetamol
boolean
C0006949 (UMLS CUI [1])
C0000970 (UMLS CUI [2])
Substance Use Disorders
Item
drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation period
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Lymphatic Radiation Therapy Complete | Monoclonal Antibody Therapy | Anti-CD4 Monoclonal Antibody | Campath 1H | natalizumab | Mitoxantrone | Cyclophosphamide | Cyclosporine | Azathioprine
Item
treatment at any time before or during study with complete lymphoradiation, monoclonal antibodies (e.g. anti-cd4, campath 1h, natalizumab), mitoxantrone, cyclophosphamide, cyclosporin, azathioprine
boolean
C0086572 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0279694 (UMLS CUI [2])
C3831519 (UMLS CUI [3])
C1178562 (UMLS CUI [4])
C1172734 (UMLS CUI [5])
C0026259 (UMLS CUI [6])
C0010583 (UMLS CUI [7])
C0010592 (UMLS CUI [8])
C0004482 (UMLS CUI [9])
Biological Response Modifiers | Exception Interferon beta-1b | Exception Methylprednisolone Intravenous
Item
treatment within 6 months before randomization with any other immunomodulatory substance than interferon-β1b or intravenous methylprednisolone
boolean
C0005525 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0244713 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0025815 (UMLS CUI [3,2])
C1522726 (UMLS CUI [3,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial